TGFB1 and pulmonary fibrosis: A low dose of anti-αvβ6 antibody was demonstrated to partially block TGF-β activity and attenuate collagen expression without increasing the alveolar inflammatory cell population or macrophage activation in a mouse pulmonary fibrosis model [43].